This post is sponsored by CONVERGE.
MedCity CONVERGE is where the entire B2B healthcare ecosystem gathers to discover the latest strategies, solutions and startups in healthcare innovation. The 3rd annual CONVERGE will take place July 15-16 in Philadelphia.
Payers, providers, medtech, pharma, digital health, startups and investors will all come together at CONVERGE to focus on healthcare’s greatest opportunities and challenges. Find out more here.
CONVERGE gives you actionable insights as well as valuable connections that will empower you to guide your organization in the near-term.
You will save $200 off the full price of CONVERGE when you register by June 16.
We’ve recently added many more speakers and some new sessions to our CONVERGE program.
The Latest Implementations of Personalized Medicine
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
One of the biggest opportunities in healthcare today is personalized medicine. But while it holds so much promise, issues such as integrating the data and information remain a major challenge. We’ve assembled implementers and investors who will discuss their experiences and the barriers that are about to fall. Learn the best approaches to further realizing the promise and benefits of personalized medicine.
Speakers:
- Andrew Jay, M.D., Investment Partner, Siemens Venture Capital (@SiemensHealth). Dr. Andrew Jay is the Head of the HealthCare Fund at Siemens Venture Capital, which invests globally in imaging, diagnostics and HIT arenas.
- Gerald McDougall, Principal and Personalized Medicine and Health Sciences Leader,PwC Health (@PwC_LLP). Gerry is Partner in charge of PwC’s Health Sciences Practice serving academic and research organizations across the healthcare continuum.
- Carol Isaacson Barash, Ph.D., Founder and Principal, Helix Health Advisors (@cisaacsonbarash ) (@Helix_Health), a consultancy specializing in integrating transformative genomic technologies to point of care delivery. Carol has 25 years of experience in genetics/genomics technologies, bioethics and applications to clinical care.
- Hakon Hakonarson, M.D., Ph.D., Director, Center for Applied Genomics, The Children’s Hospital of Philadelphia (@ChildrensPhila)
Find the full list of speakers here. Save $200 — register now.
How Healthcare Will Support Startups: In Dollars & Beyond
A few weeks ago we wrote about a couple of speakers for our Startup session, which will discuss new funding and support opportunities for early-stage companies. Read more here.
We have added:
Daphne Zohar, Founder and CEO, Pure Tech Ventures (@PureTech), a venture creation company tackling tomorrow’s biggest healthcare problems with cross-disciplinary innovation. PureTech’s pipeline of over a dozen products includes a number of clinical stage programs.
Ms. Zohar was recognized by Fierce Biotech as one of the “Top 10 Women in Biotech,” by BioWorld as one of 28 leaders predicted to be the “movers and shakers” of the biotechnology industry over the next 20 years, by MIT’s Technology Review as one of the TR35 Innovators, and by the Boston Globe as one of the “Top 15 Innovators” and one of “10 Most Influential Women.”
Check out the CONVERGE full agenda.
Register here by June 16.
Special Speaker Series: Health Insurance Innovation
How Will Payers Continue to Transform Healthcare?
We’ve put together a series of keynote-level conversations from two of the leading health insurance executives from some of the country’s most important payers. Anthony V. Coletta, CEO, Tandigm Health, and Jaja Okigwe, Senior Vice President, Strategic Development, Premera, will address some of the biggest challenges and opportunities in healthcare: from population health and fostering innovation to managing the realities of healthcare reform and their embrace of digital technologies.
- Anthony V. Coletta, M.D., is President and CEO of Tandigm Health, a groundbreaking joint venture by Independence Blue Cross (Independence) (@IBX) and Health Care Partners, LLC that works in tandem with primary care physicians to create a new paradigm of high-quality, affordable health care in the Philadelphia region.
- Jaja Okigweis Senior Vice President of Strategic Development for Premera. Okigwe oversees Premera’s corporate development function, which includes strategy formulation, strategic initiative development, incubation of new healthcare programs, and Premera’s Innovation Programs.
I urge you to make plans now to attend. Only CONVERGE gives you the entire picture, allowing you to make the best strategic decisions to run your organization.
Take advantage of our earlybird rates and register now to save $200 off the full price.
MedCity CONVERGE will be held July 15-16 in Philadelphia at the Sheraton Downtown. CONVERGE is the only event that brings together all sectors of healthcare—payers, providers, medtech, pharma, digital health, investors, policymakers and their support systems—providing a unique opportunity to fully understand and address the challenges of the future of healthcare innovation. Register today.
